In last trading session, Pliant Therapeutics Inc (NASDAQ:PLRX) saw 1.06 million shares changing hands with its beta currently measuring 1.36. Company’s recent per share price level of $1.3 trading at -$0.08 or -5.80% at ring of the bell on the day assigns it a market valuation of $79.80M. That closing price of PLRX’s stock is at a discount of -1138.46% from its 52-week high price of $16.10 and is indicating a premium of 15.38% from its 52-week low price of $1.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.78 million shares which gives us an average trading volume of 996.86K if we extend that period to 3-months.
For Pliant Therapeutics Inc (PLRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.80. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Pliant Therapeutics Inc (NASDAQ:PLRX) trade information
Upright in the red during last session for losing -5.80%, in the last five days PLRX remained trading in the red while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $1.3 price level, adding 9.09% to its value on the day. Pliant Therapeutics Inc’s shares saw a change of -88.55% in year-to-date performance and have moved -0.76% in past 5-day. Pliant Therapeutics Inc (NASDAQ:PLRX) showed a performance of 1.56% in past 30-days. Number of shares sold short was 3.36 million shares which calculate 3.14 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 2.5 to the stock, which implies a rise of 48.0% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -53.85% in reaching the projected high whereas dropping to the targeted low would mean a loss of -53.85% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -78.30% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 28.78% while estimates for its earnings growth in next 5 years are of 31.14%.
Pliant Therapeutics Inc (NASDAQ:PLRX)’s Major holders
Insiders are in possession of 3.04% of company’s total shares while institution are holding 101.02 percent of that, with stock having share float percentage of 104.19%. Investors also watch the number of corporate investors in a company very closely, which is 101.02% institutions for Pliant Therapeutics Inc that are currently holding shares of the company. DEEP TRACK CAPITAL, LP is the top institutional holder at PLRX for having 5.97 million shares of worth $64.2 million. And as of 2024-06-30, it was holding 9.8907 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 4.97 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.2335 of outstanding shares, having a total worth of $53.45 million.
